<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vose AK</submitter><funding>NICHD NIH HHS</funding><funding>Medical Research and Materiel Command</funding><funding>Congressionally Directed Medical Research Programs</funding><funding>Saskatchewan Health Research Foundation</funding><funding>Lungs for Life Foundation</funding><funding>Wings for Life Spinal Cord Research Foundation</funding><funding>Evelyn F Mcknight Brain Research Foundation</funding><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Defense</funding><funding>National Institutes of Health</funding><funding>US Army Medical Research and Materiel Command</funding><funding>Craig H. Neilsen Foundation</funding><pagination>113891</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8820239</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>347</volume><pubmed_abstract>We review progress towards greater mechanistic understanding and clinical translation of a strategy to improve respiratory and non-respiratory motor function in people with neuromuscular disorders, therapeutic acute intermittent hypoxia (tAIH). In 2016 and 2020, workshops to create and update a "road map to clinical translation" were held to help guide future research and development of tAIH to restore movement in people living with chronic, incomplete spinal cord injuries. After briefly discussing the pioneering, non-targeted basic research inspiring this novel therapeutic approach, we then summarize workshop recommendations, emphasizing critical knowledge gaps, priorities for future research effort, and steps needed to accelerate progress as we evaluate the potential of tAIH for routine </pubmed_abstract><journal>Experimental neurology</journal><pubmed_title>Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease.</pubmed_title><pmcid>PMC8820239</pmcid><funding_grant_id>SCI130298</funding_grant_id><funding_grant_id>R01HD081274</funding_grant_id><funding_grant_id>WFL-US-026</funding_grant_id><funding_grant_id>R01HL147554</funding_grant_id><funding_grant_id>R01 HL147554</funding_grant_id><funding_grant_id>R01 HD081274</funding_grant_id><funding_grant_id>W81XWH-15-2-0045</funding_grant_id><pubmed_authors>Welch JF</pubmed_authors><pubmed_authors>Fox EJ</pubmed_authors><pubmed_authors>Mitchell GS</pubmed_authors><pubmed_authors>Trumbower RD</pubmed_authors><pubmed_authors>Nair J</pubmed_authors><pubmed_authors>Dale EA</pubmed_authors><pubmed_authors>Vose AK</pubmed_authors><pubmed_authors>Muir GD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease.</name><description>We review progress towards greater mechanistic understanding and clinical translation of a strategy to improve respiratory and non-respiratory motor function in people with neuromuscular disorders, therapeutic acute intermittent hypoxia (tAIH). In 2016 and 2020, workshops to create and update a "road map to clinical translation" were held to help guide future research and development of tAIH to restore movement in people living with chronic, incomplete spinal cord injuries. After briefly discussing the pioneering, non-targeted basic research inspiring this novel therapeutic approach, we then summarize workshop recommendations, emphasizing critical knowledge gaps, priorities for future research effort, and steps needed to accelerate progress as we evaluate the potential of tAIH for routine </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-22T10:10:48.572Z</modification><creation>2025-04-05T23:26:35.915Z</creation></dates><accession>S-EPMC8820239</accession><cross_references><pubmed>34637802</pubmed><doi>10.1016/j.expneurol.2021.113891</doi></cross_references></HashMap>